e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Biomarkers, immunology and molecular pathology of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma
Elisa Lappi-Blanco (Oulu, Finland), Elisa Lappi-Blanco, Johanna Mäkinen, Kirsi Laitakari, Shirley Johnson, Riitta Mäkitaro, Risto Bloigu, Siri Lehtonen, Timo Väisänen, Riitta Kaarteenaho
Source:
International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Session:
Biomarkers, immunology and molecular pathology of lung cancer
Session type:
Poster Discussion
Number:
534
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Elisa Lappi-Blanco (Oulu, Finland), Elisa Lappi-Blanco, Johanna Mäkinen, Kirsi Laitakari, Shirley Johnson, Riitta Mäkitaro, Risto Bloigu, Siri Lehtonen, Timo Väisänen, Riitta Kaarteenaho. MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma. Eur Respir J 2015; 46: Suppl. 59, 534
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Is there a difference in the incidence of metastasis at diagnosis of lung cancer between smokers and non smokers?
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Correlation between EGFR mutations and emphysematous changes in heavy smokers with lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Prognostic relevance of histological subtypes in lung cancer – Survival in frequent and rare entities
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Serum osteopontin as a prognostic marker in patients with lung cancer
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Clinical features and prognosis of multiple primary malignancies in patients with lung cancer
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Prognostic factors in non-small cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
MUC1 gene polymorphism and serum KL-6 in lung adenocarcinoma
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Prevalence of molecular changes in resected pulmonary adenocarcinomas
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Methylation of p16 in EBUS-TBNA samples as a predictor of advanced disease in lung cancer
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013
Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor?
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome in resected non-small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Impact of persistence of smoking on recurrence after early stage lung surgery
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept